Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors

AAV analysis determine titer, full:empty capsid ratio and aggregation in single 30 min. run  

Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, announces the release of a novel method suitable for determining multiple critical quality attributes of adeno-associated virus and similar small gene vectors, in a single chromatographic run.   

The method is based on SEC-MALS, which combines size-exclusion chromatography for separation with multi-angle light scattering for characterization. SEC-MALS was introduced by Wyatt in 1985 and has been a mainstay of biophysical characterization of biotherapeutics such as monoclonal antibodies and virus-like particles. It utilizes Wyatt’s DAWN MALS instrument coupled to an industry-standard SEC system and offers full support for FDA 21CFR(11) compliance.

Critical quality attributes are the basic lot release specifications a biotherapeutic product must meet in order to ensure safety and efficacy. Typically, each CQA requires a separate assay, some of which can be laborious and time-consuming with relatively low reliability. The new SEC-MALS AAV analysis determines three CQAs: total capsid titer, the fraction of capsids without the requisite gene cargo, and the amount of aggregated viruses. All this is carried out in a single precise and automated measurement that takes just thirty minutes, enabling producers of these gene therapies to develop, market and supply these life-enhancing products faster and with greater confidence.

This unique SEC-MALS AAV analysis provides great value to our customers in the gene therapy space. They have validated it against previous standard methods and found that it not only saves time and effort, but also provides more accurate and reliable results at lower cost. The tripleCQA AAV analysis method is a home run.

Michelle Chen, Ph.D., VP of Analytical Services at Wyatt Technology

Developing novel means for characterizing gene vectors is just one more way that Wyatt Technology fulfills its mission: to help ensure our customers’ success in providing leadingedge, life-enhancing products. Additional information on these ground-breaking instruments can be found at https://www.wyatt.com/GeneTherapy.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Waters | Wyatt Technology. (2020, April 08). Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors. News-Medical. Retrieved on June 18, 2024 from https://www.news-medical.net/news/20200408/Wyatt-Technology-Pioneers-Multi-CQA-Method-for-Gene-Vectors.aspx.

  • MLA

    Waters | Wyatt Technology. "Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors". News-Medical. 18 June 2024. <https://www.news-medical.net/news/20200408/Wyatt-Technology-Pioneers-Multi-CQA-Method-for-Gene-Vectors.aspx>.

  • Chicago

    Waters | Wyatt Technology. "Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors". News-Medical. https://www.news-medical.net/news/20200408/Wyatt-Technology-Pioneers-Multi-CQA-Method-for-Gene-Vectors.aspx. (accessed June 18, 2024).

  • Harvard

    Waters | Wyatt Technology. 2020. Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors. News-Medical, viewed 18 June 2024, https://www.news-medical.net/news/20200408/Wyatt-Technology-Pioneers-Multi-CQA-Method-for-Gene-Vectors.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The Emerging Field of Gene Therapy with Adeno-Associated Viruses